These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9283511)

  • 1. Noradrenergic and serotonergic function in posttraumatic stress disorder.
    Southwick SM; Krystal JH; Bremner JD; Morgan CA; Nicolaou AL; Nagy LM; Johnson DR; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1997 Aug; 54(8):749-58. PubMed ID: 9283511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal noradrenergic function in posttraumatic stress disorder.
    Southwick SM; Krystal JH; Morgan CA; Johnson D; Nagy LM; Nicolaou A; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1993 Apr; 50(4):266-74. PubMed ID: 8466387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yohimbine use in a natural setting: effects on posttraumatic stress disorder.
    Southwick SM; Morgan CA; Charney DS; High JR
    Biol Psychiatry; 1999 Aug; 46(3):442-4. PubMed ID: 10435213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
    Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
    Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD.
    Rasmusson AM; Hauger RL; Morgan CA; Bremner JD; Charney DS; Southwick SM
    Biol Psychiatry; 2000 Mar; 47(6):526-39. PubMed ID: 10715359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
    Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR
    Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
    McDougle CJ; Black JE; Malison RT; Zimmermann RC; Kosten TR; Heninger GR; Price LH
    Arch Gen Psychiatry; 1994 Sep; 51(9):713-9. PubMed ID: 8080348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
    Charney DS; Woods SW; Goodman WK; Heninger GR
    Am J Psychiatry; 1987 Aug; 144(8):1030-6. PubMed ID: 3037926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and neuroendocrine responses to sodium lactate infusion in subjects with posttraumatic stress disorder.
    Jensen CF; Keller TW; Peskind ER; McFall ME; Veith RC; Martin D; Wilkinson CW; Raskind MA
    Am J Psychiatry; 1997 Feb; 154(2):266-8. PubMed ID: 9016280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yohimbine facilitated acoustic startle in combat veterans with post-traumatic stress disorder.
    Morgan CA; Grillon C; Southwick SM; Nagy LM; Davis M; Krystal JH; Charney DS
    Psychopharmacology (Berl); 1995 Feb; 117(4):466-71. PubMed ID: 7604149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects.
    Klein E; Zohar J; Geraci MF; Murphy DL; Uhde TW
    Biol Psychiatry; 1991 Nov; 30(10):973-84. PubMed ID: 1756202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
    Charney DS; Heninger GR; Breier A
    Arch Gen Psychiatry; 1984 Aug; 41(8):751-63. PubMed ID: 6742977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls.
    Gurguis GN; Vitton BJ; Uhde TW
    Psychiatry Res; 1997 Jun; 71(1):27-39. PubMed ID: 9247979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder.
    Bremner JD; Innis RB; Ng CK; Staib LH; Salomon RM; Bronen RA; Duncan J; Southwick SM; Krystal JH; Rich D; Zubal G; Dey H; Soufer R; Charney DS
    Arch Gen Psychiatry; 1997 Mar; 54(3):246-54. PubMed ID: 9075465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder.
    Goddard AW; Woods SW; Sholomskas DE; Goodman WK; Charney DS; Heninger GR
    Psychiatry Res; 1993 Aug; 48(2):119-33. PubMed ID: 8416022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.
    Krystal JH; Webb E; Cooney N; Kranzler HR; Charney DS
    Arch Gen Psychiatry; 1994 Nov; 51(11):898-911. PubMed ID: 7944878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol dependence may be the missing link between posttraumatic stress disorder and panic.
    Wiseman EJ
    Arch Gen Psychiatry; 1994 May; 51(5):429-30. PubMed ID: 8179467
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship of panic disorder to posttraumatic stress disorder.
    Safadi G; Bradwejn J
    Arch Gen Psychiatry; 1995 Jan; 52(1):76-8. PubMed ID: 7811165
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates.
    Rosenblum LA; Coplan JD; Friedman S; Bassoff T; Gorman JM; Andrews MW
    Biol Psychiatry; 1994 Feb; 35(4):221-7. PubMed ID: 8186327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder.
    Kellner M; Wiedemann K; Yassouridis A; Levengood R; Guo LS; Holsboer F; Yehuda R
    Biol Psychiatry; 2000 Jan; 47(2):107-11. PubMed ID: 10664826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.